pH Pharma Co., Ltd.
Records under this name other than the patents pH Pharma Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Showing 1 to 7 of 7 · Back to pH Pharma Co., Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,316,001 | Method for Producing (4S)-4-[4-Cyano-2-(METHYLSULFONYL)PHENYL]-3,6-Dimethyl-2-OXO-1-[3-(TRIFLUOROMETHYL)PHENYL]-1,2,3,4-Tetrahydro PYRIMIDINE-5-Carbonitrile Formerly held In force · High confidence | In force | High confidence | |
| US 8,815,873 | Heterocyclic Amides as Rock Inhibitors Lapsed on the fee record Ended Aug 26, 2026 · High confidence | Lapsed on the fee record | Ended Aug 26, 2026 | High confidence |
| US 8,691,817 | Sulfonic Amide and Sulfoximine-Substttuted Diaryl-Dihydropyrimidinones and Usage Thereof Lapsed on the fee record Ended Apr 8, 2026 · High confidence | Lapsed on the fee record | Ended Apr 8, 2026 | High confidence |
| US 8,580,800 | 1,4-Diaryl-PYRIMIDOPYRIDAZINE-2,5-Diones and Their Use Lapsed on the fee record Ended Nov 12, 2025 · High confidence | Lapsed on the fee record | Ended Nov 12, 2025 | High confidence |
| US 8,569,314 | Triazolo and Tetrazolo Pyrimidine Derivatives as Hne Inhibitors for Treating Copd Lapsed on the fee record Ended Oct 29, 2025 · High confidence | Lapsed on the fee record | Ended Oct 29, 2025 | High confidence |
| US 8,288,402 | 4-(4-Cyano-2-Thioaryl)DIHYDROPYRIMIDINONES and Their Use Lapsed on the fee record Ended Oct 16, 2024 · High confidence | Lapsed on the fee record | Ended Oct 16, 2024 | High confidence |
| US 9,394,286 | Rock inhibitors Lapsed on the fee record Ended Jul 19, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jul 19, 2024 | From the USPTO record |